Pronađeno: 11-20 / 55 radova

Autori: Bila Jelena S

>> Prikaži sve rezultate

Naslov Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article)
Autori Dimopoulos Meletios Athanasios  ...  Bila Jelena S  ...  (broj koautora 21) 
Info LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824
Projekat European Myeloma Network; Janssen Research Development
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (Review)
Autori Ludwig Heinz  ...  Bila Jelena S  ...  (broj koautora 29) 
Info LANCET ONCOLOGY, (2023), vol. 24 br. 6, str. E255-E269
Projekat Austrian Forum Against Cancer
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review (Review)
Autori Jovicevic Vanja  Bila Jelena S  Mesaros Sarlota T  Pekmezovic Tatjana D  Drulovic Jelena S 
Info SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, (2022), vol. 150 br. 5-6, str. 354-356
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (Article)
Autori Terpos Evangelos  ...  Bila Jelena S  ...  (broj koautora 23) 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2022), vol. 97 br. 4, str. 481-490
Projekat European Myeloma Network (EMN); Janssen Research & Development, LLC; Janssen Global Services, LLC
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases (Article)
Autori Gerhardt Kristin  ...  Sretenovic Aleksandra M  ...  Todorovic Milena R  Bila Jelena S  ...  Vucinic Vladan 
Info FRONTIERS IN ONCOLOGY, (2021), vol. 11 br. , str. -
Projekat German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group (Review)
Autori Bila Jelena S  Katodritou Eirini  Guenova Margarita  Basic-Kinda Sandra  Coriu Daniel  Dapcevic Milena  Ibricevic-Balic Lejla  Ivanaj Arben  Karanfilski Oliver  Zver Samo  Beksac Meral  Terpos Evangelos  Dimopoulos Meletios Athanassios 
Info JOURNAL OF CLINICAL MEDICINE, (2021), vol. 10 br. 17, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (Article)
Autori Dimopoulos Meletios Athanasios  ...  Bila Jelena S  ...  (broj koautora 23) 
Info LANCET ONCOLOGY, (2021), vol. 22 br. 6, str. 801-812
Projekat European Myeloma Network; Janssen Research and Development
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome (Article)
Autori Beksac Meral  Seval Guldane Cengiz  Kanellias Nicholas  Coriu Daniel  Rosinol Laura  Ozet Gulsum  Goranova-Marinova Vesselina  Unal Ali  Bila Jelena S  Ozsan Hayri  Ivanaj Arben  Ibricevic-Balic Lejla  Kastritis Efstathios  Blade Joan  Dimopoulos Meletios Athanasios 
Info HAEMATOLOGICA, (2020), vol. 105 br. 1, str. 201-208
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial (Article)
Autori Grosicki Sebastian  ...  Bila Jelena S  ...  (broj koautora 58) 
Info LANCET, (2020), vol. 396 br. 10262, str. 1563-1573
Projekat Karyopharm Therapeutics
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Influence of applied CD34(+) cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants (Article)
Autori Todorovic-Balint Milena R  Bila Jelena S  Balint Bela J  Jelicic Jelena J  Djunic Irena S  Antic Darko A  Kraguljac-Kurtovic Nada  Vujic Dragana S  Mihaljevic Biljana S 
Info VOJNOSANITETSKI PREGLED, (2020), vol. 77 br. 8, str. 844-851
Projekat Ministry of Education, Science and Technological Development of the Republic of Serbia [41004, "III" 41030]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX